SS
Sarjeevan Singh
About Sarjeevan Singh
Data last updated:
Sarjeevan Singh is a Director at Shukra Pharmaceuticals Limited (since 2023), Director at Navkar Urbanstructure Limited (since 2018) and Director at Seher Retail Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Pharma, Manufacturing and Art. The 5 current companies with reported revenue have a combined latest revenue of ₹70.17 Cr; the largest is Shukra Pharmaceuticals Limited at ₹36.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shukra Pharmaceuticals Limited L24231GJ1993PLC019079 | Director | 16 Aug 2023 | 1993 | ₹36.79 Cr (FY 2025) | Active |
 Navkar Urbanstructure Limited L45200GJ1992PLC017761 | Director | 14 Nov 2018 | 1992 | ₹12.80 Cr (FY 2023) | Active |
 Seher Retail Private Limited U51502GJ2010PTC060125 | Director | 18 Mar 2023 | 2010 | ₹11.53 Cr (FY 2024) | Active |
 Madhuveer Com 18 Network Limited L93000GJ1995PLC026244 | Director | 26 Feb 2025 | 1995 | ₹5.92 Cr (FY 2025) | Active |
| Softrak Venture Investment Limited L99999GJ1993PLC020939 | Director | 15 Jun 2020 | 1993 | ₹3.13 Cr (FY 2025) | Active |
Board colleagues of Sarjeevan Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarjeevan Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarjeevan Singh
Sarjeevan Singh currently holds 5 directorships: Shukra Pharmaceuticals Limited (Director, since 16 Aug 2023, revenue ₹36.79 Cr (FY 2025)); Navkar Urbanstructure Limited (Director, since 14 Nov 2018, revenue ₹12.80 Cr (FY 2023)); Seher Retail Private Limited (Director, since 18 Mar 2023, revenue ₹11.53 Cr (FY 2024)); Madhuveer Com 18 Network Limited (Director, since 26 Feb 2025, revenue ₹5.92 Cr (FY 2025)); Softrak Venture Investment Limited (Director, since 15 Jun 2020, revenue ₹3.13 Cr (FY 2025)).
Sarjeevan Singh was first appointed on 14 Nov 2018 as Director at Navkar Urbanstructure Limited. The most recent appointment on record is 26 Feb 2025 at Madhuveer Com 18 Network Limited.
The 5 current companies of Sarjeevan Singh that report revenue have a combined latest revenue of ₹70.17 Cr: Shukra Pharmaceuticals Limited ₹36.79 Cr (FY 2025); Navkar Urbanstructure Limited ₹12.80 Cr (FY 2023); Seher Retail Private Limited ₹11.53 Cr (FY 2024); Madhuveer Com 18 Network Limited ₹5.92 Cr (FY 2025); Softrak Venture Investment Limited ₹3.13 Cr (FY 2025).
The current boards of Sarjeevan Singh's companies include Anar Jayeshbhai Patel (Shukra Pharmaceuticals Limited), Anar Jayeshbhai Patel (Shukra Pharmaceuticals Limited), Dakshesh Rameshchandra Shah (Shukra Pharmaceuticals Limited), Dhruvin Shah (Shukra Pharmaceuticals Limited), Dinesh Chauhan (Shukra Pharmaceuticals Limited), Jitendra Somchand Shah (Shukra Pharmaceuticals Limited), among others.